Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its extensive portfolio of generic and branded medications, has been facing headwinds in recent months. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international companies. A fina